# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001171843-22-005818
Filing Date
2022-08-25
Accepted
2022-08-25 07:03:46
Documents
17
Period of Report
2022-08-25
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | f8k_082522.htm iXBRL | 8-K | 19113
2 | EXHIBIT 10.1 | exh_101.htm | EX-10.1 | 1171
3 | PRESS RELEASE | exh_991.htm | EX-99.1 | 10569
4 |  | exh101_1.jpg | GRAPHIC | 3287882
5 |  | exh101_2.jpg | GRAPHIC | 1132986
| Complete submission text file | 0001171843-22-005818.txt |  | 6314344

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | gnw-20190101.xsd | EX-101.SCH | 3069
7 | XBRL DEFINITION FILE | gnw-20190101_def.xml | EX-101.DEF | 25640
8 | XBRL LABEL FILE | gnw-20190101_lab.xml | EX-101.LAB | 34011
9 | XBRL PRESENTATION FILE | gnw-20190101_pre.xml | EX-101.PRE | 22139
11 | EXTRACTED XBRL INSTANCE DOCUMENT | f8k_082522_htm.xml | XML | 3013

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 221192952
SIC: 2836 Biological Products, (No Diagnostic Substances)